Venus Remedies Limited (BOM:526953)

Market Cap	9.71B
Revenue (ttm)	6.99B
Net Income (ttm)	703.05M
Shares Out	13.37M
EPS (ttm)	52.64
PE Ratio	13.80
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	648
Average Volume	1,701
Open	692.05
Previous Close	721.40
Day's Range	687.05 - 740.00
52-Week Range	272.20 - 848.90
Beta	0.32
RSI	50.61
Earnings Date	Jan 29, 2026

About Venus Remedies

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, and solvent products, as well as herbal medicine. The c...

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 1,298
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 526953

Financial Performance

In 2024, Venus Remedies's revenue was 6.48 billion, an increase of 7.72% compared to the previous year's 6.01 billion. Earnings were 453.15 million, an increase of 59.05%.